Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - BARRIS PETER J
Last Updated 
20-Mar-17
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

BARRIS PETER J: Declared Holdings
Company/RelationshipReportedShares  Ownership
Adaptimmune Therapeutics plc
Beneficial Owner (10% or more)
NasdaqGS:ADAP
(historical quotes, profile, other insiders)
1-Jan-1659,269,000  Indirect
Achaogen, Inc.
Beneficial Owner (10% or more)
NasdaqGM:AKAO
(historical quotes, profile, other insiders)
19-Dec-165,215,128  Indirect
Ardelyx, Inc.
Beneficial Owner (10% or more)
NasdaqGM:ARDX
(historical quotes, profile, other insiders)
18-Jul-1614,084,162  Indirect
AVEO Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGS:AVEO
(historical quotes, profile, other insiders)
13-May-1610,362,694  Indirect
Cascadian Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGS:CASC
(historical quotes, profile, other insiders)
27-Jan-179,064,574  Indirect
Epizyme, Inc.
Beneficial Owner (10% or more)
NasdaqGS:EPZM
(historical quotes, profile, other insiders)
12-Jan-166,261,599  Indirect
GlycoMimetics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:GLYC
(historical quotes, profile, other insiders)
16-Nov-158,584,128  Indirect
Groupon, Inc.
Director
NasdaqGS:GRPN
(historical quotes, profile, other insiders)
8-Jun-16
2-Mar-17
116,923
   15,534,817
15,651,740
  Direct
  Indirect  
  Total
INTERLEUKIN GENETICS
Beneficial Owner (10% or more)
Other OTC:ILIU
(historical quotes, profile, other insiders)
29-Jul-1655,418,811  Indirect
Mirna Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:MIRN
(historical quotes, profile, other insiders)
6-Oct-152,971,517  Indirect
MULESOFT, INC
Beneficial Owner (10% or more)
NYSE:MULE
(historical quotes, profile, other insiders)
16-Mar-17320,780  Indirect
Ra Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:RARX
(historical quotes, profile, other insiders)
31-Oct-163,490,073  Indirect
Senseonics Holdings, Inc.
Beneficial Owner (10% or more)
NYSE MKT:SENS
(historical quotes, profile, other insiders)
23-Mar-1626,330,980  Indirect
Supernus Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:SUPN
(historical quotes, profile, other insiders)
11-Nov-154,203,312  Indirect
TRACON Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:TCON
(historical quotes, profile, other insiders)
29-Nov-162,758,039  Indirect
TESARO, Inc.
Beneficial Owner (10% or more)
NasdaqGS:TSRO
(historical quotes, profile, other insiders)
18-Mar-1610,276,647  Indirect
Vitae Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGS:VTAE
(historical quotes, other insiders)
1-Jul-151,789,352  Indirect
XTERA COMMUNICATIO COM USD0.001
Beneficial Owner (10% or more)
Other OTC:XCOMQ
(historical quotes, profile, other insiders)
17-Nov-153,631,537  Indirect

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
16-Mar-17 *320,780MULE Statement of Ownership
2-Mar-17 *75,000GRPN Sale at $4.19 per share.
(Proceeds of $314,250)
1-Mar-17 *112,386GRPN Sale at $4.21 per share.
(Proceeds of $473,145)
28-Feb-17 *93,968GRPN Sale at $4.26 per share.
(Proceeds of $400,303)
27-Feb-17 *6,535,000GRPN Disposition (Non Open Market) at $0 per share.
27-Feb-17 *1,904,302GRPN Acquisition (Non Open Market) at $0 per share.
27-Jan-17 *9,064,574CASC Statement of Ownership
19-Dec-16 *500,000AKAO Purchase at $13.50 per share.
(Cost of $6,750,000)
29-Nov-16 *869,565TCON Purchase at $5.75 per share.
(Cost of $4,999,998)
31-Oct-16 *80,658RARX Option Exercise at $0.07 per share.
(Cost of $5,646)
31-Oct-16 *338,462RARX Purchase at $13 per share.
(Cost of $4,400,006)
31-Oct-16 *3,071,388RARX Acquisition (Non Open Market)
31-Oct-16 *435RARX Sale at $13 per share.
(Proceeds of $5,655)
12-Aug-16 *730,349GRPN Sale at $5.69 per share.
(Proceeds of $4,155,685)
11-Aug-16 *4,945,096GRPN Acquisition (Non Open Market) at $0 per share.
11-Aug-16 *16,971,337GRPN Disposition (Non Open Market) at $0 per share.
29-Jul-16 *20,120,724ILIU Purchase at $0.10 - $0.1 per share.
(Cost of about $2,012,000)
18-Jul-16 *2,290,951ARDX Purchase at $8.73 - $8.73 per share.
(Cost of about $20,000,000)
10-Jun-16 *358,382GRPN Sale at $3.20 - $3.2 per share.
(Proceeds of about $1,147,000)
9-Jun-16 *281,663GRPN Sale at $3.26 - $3.26 per share.
(Proceeds of about $918,000)
8-Jun-16 *14,377,000GRPN Disposition (Non Open Market) at $0 per share.
8-Jun-16 *4,189,110GRPN Acquisition (Non Open Market) at $0 per share.
8-Jun-16 45,991GRPN Acquisition (Non Open Market) at $0 per share.
3-Jun-16 *4,715,128AKAO Statement of Ownership
13-May-16 *10,362,694AVEO Statement of Ownership
23-Mar-16 *2,631,578SENS Purchase at $2.85 - $2.85 per share.
(Cost of about $7,500,000)
18-Mar-16 *1,420,858TSRO Purchase at $35.19 - $35.19 per share.
(Cost of about $50,000,000)
17-Mar-16 *23,699,402SENS Statement of Ownership
13-Jan-16 *1,500,000ARDX Purchase at $10 - $10 per share.
(Cost of about $15,000,000)
12-Jan-16 *1,111,111EPZM Purchase at $9 - $9 per share.
(Cost of about $10,000,000)
1-Jan-16 *59,269,000ADAP Statement of Ownership
17-Nov-15 *800,000XCOMQ Purchase at $5 - $5 per share.
(Cost of about $4,000,000)
17-Nov-15 *2,797,219XCOMQ Acquisition (Non Open Market)
16-Nov-15 *9,445GLYC Option Exercise at $0.33 - $0.33 per share.
(Cost of about $3,116)
16-Nov-15 *452GLYC Sale at $6.91 - $6.91 per share.
(Proceeds of about $3,123)
12-Nov-15 *34,318XCOMQ Statement of Ownership
11-Nov-15 *4,993,557SUPN Disposition (Non Open Market) at $0 per share.
11-Nov-15 *1,480,814SUPN Acquisition (Non Open Market) at $0 per share.
6-Oct-15 *857,142MIRN Purchase at $7 - $7 per share.
(Cost of about $6,000,000)
6-Oct-15 *289,166MIRN Acquisition (Non Open Market) at $0 per share.
5-Oct-15 *1,825,209MIRN Acquisition (Non Open Market)
1-Jul-15 *833,250VTAE Disposition (Non Open Market) at $0 per share.
1-Jul-15 *11,038VTAE Acquisition (Non Open Market) at $0 per share.
18-Jun-15 28,889GRPN Acquisition (Non Open Market) at $0 per share.
17-Jun-15 *111,881SUPN Sale at $16.02 - $16.67 per share.
(Proceeds of about $1,829,000)
16-Jun-15 *55,105SUPN Sale at $16.85 - $16.85 per share.
(Proceeds of about $929,000)
15-Jun-15 *1,162,791SUPN Acquisition (Non Open Market) at $0 per share.
15-Jun-15 *3,921,000SUPN Disposition (Non Open Market) at $0 per share.
5-Jun-15 *4,672,897ARDX Purchase at $10.70 - $10.7 per share.
(Cost of about $50,000,000)
2-Jun-15 *2,129TSRO Sale at $57.55 - $58.13 per share.
(Proceeds of about $123,000)
1-Jun-15 *1,010,000TSRO Disposition (Non Open Market) at $0 per share.
1-Jun-15 *12,709TSRO Acquisition (Non Open Market) at $0 per share.
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?